Table 2

Rates and relative risk estimates of SSRI prescription and non-pharmacological treatment in the first year after delivery for 206 517 women who gave birth between 2000 and 2013

SSRI prescriptionNon-pharmacological treatment
Rate per 100Adjusted RRRate per 100Adjusted RR
Age group
 15–1918.8 (18.0 to 19.5)1.78 (1.68 to 1.88)4.9 (4.5 to 5.4)1.55 (1.41 to 1.72)
 20–2415.9 (15.5 to 16.4)1.54 (1.47 to 1.61)4.4 (4.1 to 4.6)1.38 (1.28 to 1.49)
 25–2911.7 (11.5 to 12.0)1.18 (1.14 to 1.23)3.3 (3.2 to 3.5)1.11 (1.04 to 1.18)
 30–349.6 (9.4 to 9.8)12.9 (2.8 to 3.0)1
 35–399.3 (9.1 to 9.6)0.99 (0.95 to 1.03)2.9 (2.7 to 3.0)0.99 (0.92 to 1.07)
 40–499.6 (9.0 to 10.1)1.01 (0.94 to 1.07)3.1 (2.7 to 3.4)1.05 (0.93 to 1.19)
Calendar period
 2000–200411.4 (11.1 to 11.7)12.4 (2.2 to 2.5)1
 2005–200911.3 (11.1 to 11.6)0.97 (0.93 to 1.01)3.5 (3.3 to 3.6)1.43 (1.30 to 1.57)
 2010–201311.5 (11.2 to 11.7)0.96 (0.92 to 1.01)3.8 (3.6 to 3.9)1.54 (1.38 to 1.71)
Townsend Deprivation Index quantile
 18.9 (8.7 to 9.2)12.7 (2.5 to 2.8)1
 210.0 (9.7 to 10.3)1.09 (1.04 to 1.14)3.0 (2.9 to 3.2)1.10 (1.00 to 1.20)
 311.3 (11.0 to 11.6)1.19 (1.14 to 1.25)3.3 (3.1 to 3.4)1.14 (1.04 to 1.25)
 413.1 (12.7 to 13.4)1.33 (1.25 to 1.40)3.8 (3.6 to 4.0)1.29 (1.17 to 1.42)
 515.2 (14.8 to 15.6)1.47 (1.38 to 1.57)4.2 (3.9 to 4.4)1.36 (1.22 to 1.52)
  • Adjusted by age group, calendar period and Townsend Deprivation Index.

  • RR, relative risk; SSRI, selective serotonin reuptake inhibitor.